以岭药业：小儿连花清感颗粒药品注册上市申请获受理

Core Viewpoint - Yiling Pharmaceutical has received a formal acceptance notice from the National Medical Products Administration for its new drug registration application of "Xiaoer Lianhua Qinggan Granules," indicating progress in the company's innovative drug development for pediatric use [1] Group 1: Product Information - "Xiaoer Lianhua Qinggan Granules" is an innovative traditional Chinese medicine developed by the company [1] - The drug is indicated for the treatment of acute upper respiratory tract infections in children, specifically for symptoms such as fever, nasal congestion, sore throat, cough, aversion to wind, sneezing, runny nose, headache, muscle aches, pale red or red tongue, thin yellow coating, and floating rapid pulse [1]